Breast Cancer Reveals Latent BMPR2 -Related Susceptibility to Pulmonary Hypertension
Circulation · 17.02.2026 · 153 (7) · 516-533
DOI: 10.1161/circulationaha.125.079067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 17.02.2026. Verfasst von Victoria Toro und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, Canada (V.T., M.M., C.A.G., R.E.K., C. Bilode…. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein Receptors, Type II, Breast Neoplasms, Hypertension, Pulmonary. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Pulmonary arterial hypertension (PAH) and breast cancer disproportionately affect women. BMPR2 (bone morphogenetic protein receptor type 2) mutations, the most common genetic cause of heritable PAH, also exert tumor-suppressive functions, but their role in linking these diseases remains unclear. METHODS: We combined bioinformatic, epidemiologic, and experimental approaches. Public cancer datasets were mined for BMPR2 alterations. In vivo, mammary tumor development and pulmonary hemodynamics were assessed in female Bmpr2 +/Δ71 rats with or without carcinogen (7,12-dimethylbenz[a]anthracene) exposure. Pulmonary arterial smooth muscle cells were exposed to tumor-conditioned media to test inflammatory proliferation. Finally, associations between breast cancer and PAH were examined in the French National Healthcare Database (9964 patients with PAH). RESULTS: BMPR2 expression was markedly reduced in human breast tumors, with recurrent somatic variants and deep deletions identified. Bmpr2 +/Δ71 rats exhibited spontaneous mammary tumors and, following 7,12-dimethylbenz[a]anthracene exposure, developed exacerbated pulmonary hypertension with increased vascular remodeling and inflammation. Tumor-bearing Bmpr2 +/Δ71 rats showed elevated lung IL-1β and NF-κB activation. In vitro, conditioned media from Bmpr2 +/Δ71 tumors induced proliferation of Bmpr2 +/Δ71 pulmonary arterial smooth muscle cells via IL-1β–dependent signaling, while neutralization of IL-1β attenuated this effect. Human pulmonary arterial smooth muscle cells carrying BMPR2 mutations similarly displayed heightened IL-1β–induced proliferation. Epidemiologically, breast cancer incidence was more than doubled in patients with PAH compared with the general population, and PAH incidence was increased nearly 9-fold among patients with breast cancer, indicating a bidirectional relationship. CONCLUSIONS: These findings identify a reciprocal association between breast cancer and PAH mediated by defective BMPR2 signaling and tumor-associated inflammation. Breast cancer may act as a “second hit,” unmasking BMPR2 -related susceptibility to PAH, underscoring BMPR2 as a shared molecular vulnerability with implications for surveillance of at-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, Canada (V.T., M.M., C.A.G., R.E.K., C. Bilodeau, Y.G., S.M., S.B.-B., A.A.-S., O.B., S.P., S.B., F.P.).
- Université Grenoble Alpes, INSERM U1300, HP2, and INSERM CIC1406, Grenoble, France (C. Brossat, CJ.-B., A.H.).
- Pharmacovigilance Unit, CHU Grenoble Alpes, Grenoble, France (C. Brossat, CJ.-B., A.H.).
- Institut National de la Santé et de la Recherche Médicale (INSERM) unité mixte de recherche (UMR)_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis-Robinson, France…
- Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (M.B.).
- Institute for Lung Health, German Center for Lung Research (DZL), Cardio-Pulmonary Institute, Justus Liebig University Giessen, Giessen, Germany (S.B.).
ORCID-Profile: Manon Mougin, Coline Brossat, Clement Jambon-Barbara, Alex Hlavaty, Yann Grobs, Sandra Martineau, Olivier Boucherat, Malik Bisserier, Steeve Provencher, Sebastien Bonnet, David Montani, Charles Khouri, François Potus
Zitieren
APA
Toro, V., Mougin, M., Brossat, C., Jambon-Barbara, C., Hlavaty, A., Guay, C. A., El Kabbout, R., Bilodeau, C., Grobs, Y., Martineau, S., Breuils-Bonnet, S., Abi-Sleimen, A., Ruffenach, G., Boucherat, O., Bisserier, M., Provencher, S., Bonnet, S., Montani, D., Khouri, C., & Potus, F. (2026). Breast Cancer Reveals Latent BMPR2 -Related Susceptibility to Pulmonary Hypertension. Circulation, 153(7), 516-533. https://doi.org/10.1161/circulationaha.125.079067
Vancouver
Toro V, Mougin M, Brossat C, Jambon-Barbara C, Hlavaty A, Guay CA, et al. Breast Cancer Reveals Latent BMPR2 -Related Susceptibility to Pulmonary Hypertension. Circulation. 2026;153(7):516-533. doi:10.1161/circulationaha.125.079067
BibTeX
@article{Toro2026,
author = {Toro, Victoria and Mougin, Manon and Brossat, Coline and Jambon-Barbara, Clement and Hlavaty, Alex and Guay, Charles Antoine and El Kabbout, Reem and Bilodeau, Coralie and Grobs, Yann and Martineau, Sandra and Breuils-Bonnet, Sandra and Abi-Sleimen, Antonella and Ruffenach, Gregoire and Boucherat, Olivier and Bisserier, Malik and Provencher, Steeve and Bonnet, Sebastien and Montani, David and Khouri, Charles and Potus, François},
title = {Breast Cancer Reveals Latent BMPR2 -Related Susceptibility to Pulmonary Hypertension},
journal = {Circulation},
year = {2026},
volume = {153},
number = {7},
pages = {516--533},
doi = {10.1161/circulationaha.125.079067}
}
EUVIMED